
Loading, please wait...

Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
— Hippocrates

The GZF1-related phenotype (GZF1RP) is a rare genetic disorder characterized by a specific combination of ocular and skeletal abnormalities. Historically, clinicians referred to this condition by multiple names, including autosomal recessive Larsen syndrome (LRS). However, recent studies suggest that GZF1RP represents a distinct clinical entity. While patients share features like short stature and joint dislocations with LRS, the severe ocular manifestations in GZF1RP are significantly more pronounced. Researchers have now identified biallelic variants of the GZF1 gene as the primary cause of this condition.
Identifying the GZF1-related phenotype requires a careful comparison with classic Larsen syndrome caused by FLNB mutations. In contrast to FLNB-related cases, GZF1RP presents with severe ophthalmologic phenotypes. These often include congenital glaucoma, abnormal iris morphology, and severe myopia. Furthermore, the inheritance pattern is autosomal recessive, whereas classic Larsen syndrome typically follows an autosomal dominant pattern. Understanding these differences is crucial for accurate genetic counseling and patient management.
A recent study described three new patients, identifying specific GZF1 variants such as c.1440del (p.His481IlefsTer26) and c.1451_1452del (p.Cys484fs). Moreover, clinicians have identified new radiological findings that further define the GZF1-related phenotype. These findings include cervical segmentation defects, carpal shortening, and lower lumbar sacralization. Some patients also present with clinical features uncommon in previous reports, such as umbilical hernias and congenital heart disease. Consequently, the clinical profile of GZF1RP is broader than initially thought.
A recognizable GZF1RP includes a constellation of symptoms beyond joint hypermobility. Specifically, clinicians should look for severe ocular defects, facial dysmorphism, scoliosis, and thoracic deformity. Additionally, progressive hearing loss, hypodontia, and short stature are common. Because these features overlap with other connective tissue disorders, genetic testing remains the definitive diagnostic tool. Therefore, multidisciplinary teams should prioritize GZF1 testing when ocular and skeletal symptoms coexist in an autosomal recessive pattern.
Patients typically present with severe myopia, congenital glaucoma, and abnormal iris morphology. These ocular defects are often more severe than those seen in other similar skeletal disorders.
New radiological evidence identifies cervical segmentation defects, carpal shortening, and lower lumbar sacralization as specific markers for the GZF1-related phenotype.
Yes, it is an autosomal recessive disorder. This means a child must inherit two copies of the pathogenic GZF1 variant, one from each parent, to develop the condition.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional diagnosis. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Yokoyama-Rebollar E et al. Expanding the Genetic and Clinical Spectrum of GZF1-Related Phenotype: A Specific Ocular and Skeletal Disorder Distinguishable From Larsen Syndrome. Am J Med Genet A. 2026 May 22. doi: 10.1002/ajmg.a.70207. PMID: 42170786.
Patel N, et al. GZF1 Mutations Expand the Genetic Heterogeneity of Larsen Syndrome. Am J Hum Genet. 2017 May 4;100(5):831-836. PMID: 28475863.
Zeng L, et al. Novel GZF1 pathogenic variants identified in two Chinese patients with Larsen syndrome. Clin Genet. 2021;99(1):103-108. PMID: 33009817.
"
New research defines GZF1-related phenotype as a distinct disorder with severe ocular defects and unique skeletal anomalies, separate from Larsen syndrome....
Last week

A review of experimental rodent models for Cardiorenal Syndrome types 3 and 4, exploring the pathophysiology and limitations of current research models....
Today

IPA, a gut-derived metabolite, suppresses PPARγ to prevent bone loss and marrow fat accumulation, offering a potential therapeutic strategy for osteoporosis...
Today

A review of functional hydrogels for cardiovascular therapy, covering preparation, regenerative applications, and current hurdles in clinical translation....
Today

Recent research highlights the potential of plant-derived compounds to combat dexamethasone-induced muscle atrophy by targeting the FoxO transcription facto...
Today

A study reveals that patients with active mucormycosis exhibit significantly reduced natural killer cell counts, indicating a distinct immunologic phenotype...
Today